The production of secondary metabolite alkaloids by epichloë endophytes of grasses is of great interest to agriculture due to the opposing effects of pasture protection against insect herbivory and concomitant toxicity to stock. Recent molecular genetic analysis, that has greatly enhanced our understanding of secondary metabolite biosynthesis, is reviewed and potential outcomes for pastoral agr...

A metabolite profiling study of the antibiotic producing bacterium Streptomyces coelicolor A3(2) has been performed. The aim of this study was to monitor intracellular metabolite pool changes occurring as strains of S. coelicolor react to nutrient depletion with metabolic re-modeling, so-called metabolic switching, and transition from growth to secondary metabolite production phase. Two differe...

Background: Trigonella foenum-graecum L. commonly known as fenugreek is a rich source of important medicinal metabolite, i.e. trigonelline. Objective: In this study, hairy roots culture as a novel method for trigonelline production was evaluated. Methods: For optimizing the hairy roots culture of Trigonella foenum-graecum, three strains of Agrobacterium rhyzogenes (ATCC15834, MSU440 and K...

salicylic acid (sa) and methyl jasmonate (meja) as phytohormone regulate synthesis of secondary metabolites in a wide range of plant species by accumulation of phenylalanine ammonia lyase enzyme (pal) and accelerate the production of oxygen free radicals, protein kinase, proline and nitrite oxide content. to study the effect of these compounds on synthesis of secondary metabolites, in two separ...

Melissa officinalis is a perennial herbaceous plant from Lamiaceae family, widely used in food and pharmaceutical industries to add aroma. Drought stress in plants may happen due to the increase in water loss, insufficient water absorption or both. Salicylic acid (SA) is an important secondary metabolite in plants with hormone-like action in some biochemical pathways. Adding it during water-def...

Metabolism-dependent inhibition (MDI) of cytochrome P450 (P450) enzymes has the potential to cause clinically relevant drug-drug interactions. In the case of several alkylamine drugs, MDI of P450 involves formation of a metabolite that binds quasi-irreversibly to the ferrous heme iron to form a metabolic intermediate (MI) complex. The specific metabolites coordinately bound to ferrous iron and ...

Metabolism-dependent inhibition (MDI) of cytochrome P450 (P450) enzymes has the potential to cause clinically relevant drug-drug interactions. In the case of several alkylamine drugs, MDI of P450 involves formation of a metabolite that binds quasi-irreversibly to the ferrous heme iron to form a metabolic intermediate (MI) complex. The specific metabolites coordinately bound to ferrous iron and ...